Invention Grant
US07897579B2 Use of a compound comprising D-mannoheptulose and/or perseitol for treating and preventing innate immunity modification diseases
有权
含有D-甘露庚酮糖和/或去糖醇的化合物用于治疗和预防先天性免疫修饰疾病的用途
- Patent Title: Use of a compound comprising D-mannoheptulose and/or perseitol for treating and preventing innate immunity modification diseases
- Patent Title (中): 含有D-甘露庚酮糖和/或去糖醇的化合物用于治疗和预防先天性免疫修饰疾病的用途
-
Application No.: US11587961Application Date: 2005-04-29
-
Publication No.: US07897579B2Publication Date: 2011-03-01
- Inventor: Antoine Piccirilli , Nathalie Piccardi , Philippe Msika , François Paul , Stéphanie Bredif
- Applicant: Antoine Piccirilli , Nathalie Piccardi , Philippe Msika , François Paul , Stéphanie Bredif
- Applicant Address: FR Courbevoie
- Assignee: Laboratoires Expanscience
- Current Assignee: Laboratoires Expanscience
- Current Assignee Address: FR Courbevoie
- Agency: Foley & Lardner LLP
- Priority: FR0404635 20040430
- International Application: PCT/FR2005/001075 WO 20050429
- International Announcement: WO2005/115421 WO 20051208
- Main IPC: A01N43/04
- IPC: A01N43/04 ; A61K31/70 ; A61K31/45
Abstract:
The invention relates to the use of a compound comprising D-mannoheptulose and/or perseitol for producing a drug for treating and/or preventing diseases related to the modification of an innate and/or acquired immunity by increasing the production of antimicrobial peptides, preferably hBD-2 without inducing inflammatory reactions, irritation or intolerance. Said compound can also comprise a peptidic avocado extract and/or a peptidic lupin extract.
Public/Granted literature
Information query
IPC分类:
